Verbatim response from Claude
Compounded Tirzepatide Availability
This is a nuanced situation that's changed recently. Here's what you should know:
The short answer: It's becoming very limited and legally uncertain.
What Happened
The FDA removed tirzepatide (Zepbound/Mounjaro) from its drug shortage list in late 2024, which means:
- Large commercial compounding pharmacies ("503B outsourcing facilities") must stop producing it
- Smaller "503A" pharmacies serving individual patients with a valid prescription have a temporary grace period (extended into 2025)
Still Potentially Legitimate Options
- Hims & Hers - has offered compounded versions but is navigating the changing rules
- Henry Meds - similarly adjusting their offerings
- Local 503A compounding pharmacies - with a doctor's prescription, some may still compound it temporarily
- Nuvation/Strive Pharmacy - some compounders are still operating within grace periods
Important Cautions
- ⚠️ Verify any pharmacy is PCAB-accredited or state-licensed
- ⚠️ Avoid anyone selling without requiring a valid prescription
- ⚠️ This space is changing week by week - check current status
Better Long-Term Option
Manufacturer patient assistance programs (Eli Lilly) may help with cost for branded Zepbound.
Would you like help finding legitimate access to the branded version instead?